About EDUMED s.r.o
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Pfizer
2
Daiichi Sankyo, Inc.
1
InCarda Therapeutics, Inc.
1
Ionis Pharmaceuticals, Inc.
1
Kowa Research Institute, Inc.
1
Verona Pharma plc
1
Clinical Trials at EDUMED s.r.o
During the past decade, EDUMED s.r.o conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
2020-04-30
2021-11-04
Completed
413
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
2020-09-29
2022-12-02
Completed
763
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "EDUMED s.r.o" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Pfizer" with 2 trials
sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "InCarda Therapeutics, Inc." with 1 trials sponsored and "Ionis Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "EDUMED s.r.o"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at EDUMED s.r.o
According to Clinical.Site data, the most researched conditions in "EDUMED s.r.o" are
"Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "EDUMED s.r.o" in a lesser frequency.
Clinical Trials Intervention Types at EDUMED s.r.o
Most popular intervention types in "EDUMED s.r.o" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "BI 456906" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at EDUMED s.r.o
The vast majority of trials in "EDUMED s.r.o" are
10 trials for "All" genders.
Clinical Trials Status at EDUMED s.r.o
Currently, there are NaN active trials in "EDUMED s.r.o".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in EDUMED s.r.o,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in EDUMED s.r.o, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".